When the government can effectively use technology to do its job more efficiently, it typically means great things for the broader population. And in the case of medical device testing and trials conducted by the FDA, it can mean the difference between life and death for patients. Dassault Systèmes recently announced a 5-year extension of its collaboration with the FDA in using its 3DExperience tech platform to build digital tools that will enable more efficient regulatory review of medical devices including cardiovascular devices...
Sorry, you need to subscribe to read this article.
If you would like to access this article, please subscribe below.
Premium subscribers receive complete access to our site content which includes market research and insights as well as coverage of the most important news, issues and events related to the healthcare technology industry.